About Us

The Microbial Bioprocess Lab (MiBioLab) is a spin-off project of Research Centre Jülich, funded by the state of North Rhine-Westphalia and the European Union within the framework of the . Originating as a Helmholtz Innovation Lab, MiBioLab has been offering bioprocess development to industry as contract research services since 2018.

Our USP is our automation technology platform, as well as the in-depth expertise in microcultivation and data science. Pilot customers value MiBioLab as a trustworthy partner that has delivered valuable bioprocess insights and data, which have proven highly predictive during scale-up. Our long-term vision is to provide comprehensive biofoundry services from strain design to a scalable production process.

From 2025 to 2026, the MiBioLab was funded by the state of North Rhine-Westphalia and the European Union through the Start-Up Transfer.NRW program. In that period, we evaluated customer needs and key challenges for a potential contract research organization (CRO) by conducting a market study and refined our business model. Based on these insights, we decided to expand our services towards high-throughput primary strain screening, bridging the gap between strain development and bioprocess development.
While establishing these capabilities, we also consolidated our core technology platform, enabling us to deliver more reliable, and more reproducible results. Another key objective of the Start-Up Transfer.NRW project was the further integration of artificial intelligence (AI) into experimental design and data analysis. This work lays the foundation for increasingly data-driven and efficient bioprocess development workflows.

Our Team

Dr.-Ing. Bertram Geinitz

Operative Lab Head

Dr.-Ing. Michael Osthege

Lead Automation Engineer

Matthias Moch

Engineer

Prof. Marco Oldiges

Scientific Coordinator